专利检索 ap:("KoBioLabs, Inc.") AND inv:"Boram SEO" 第 1 页

1.

发明公开
COMPOSITION FOR DIAGNOSIS AND TREATMENT OF ALCOHOLIC LIVER DISEASE, USING CHANGE IN SHORT-CHAIN FATTY ACID PRODUCING GUT BACTERIAL COMMUNITY 审中-公开

公开(公告)号：US20230190829A1

公开(公告)日：2023-06-22

申请号：US18050091

申请日：2022-10-27

申请人： KoBioLabs, Inc.

发明人： Gwangpyo KO , Boram SEO , Woon Ki KIM , Kyungchan JEON

IPC分类号： A61K35/741 , A23L33/135 , A61K39/02

CPC分类号： A61K35/741 , A23L33/135 , A61K39/0208 , A61K2035/115

摘要： The present invention relates to a microorganism which can act as a biomarker of alcoholic fatty liver disease, and relates to a pharmaceutical composition for preventing or treating alcoholic fatty liver disease, a food composition for preventing or improving alcoholic fatty liver disease, or a probiotics composition for preventing or improving alcoholic fatty liver disease, comprising the strain as an active ingredient.

2.

发明公开
FAECALIBACTERIUM PRAUSNITZII STRAIN AND USES THERE OF 审中-公开

公开(公告)号：US20230293600A1

公开(公告)日：2023-09-21

申请号：US18041369

申请日：2021-08-12

申请人： KOBIOLABS, INC.

发明人： Boram SEO , Kyungchan JEON , Woon Ki KIM , Tae Wook NAM , Gwang Pyo KO , Dukyun KIM

IPC分类号： A61K35/74 , A61P29/00 , A23L33/135

CPC分类号： A61K35/74 , A61P29/00 , A23L33/135

摘要： The present invention relates to a Faecalibacterium prausnitzii strain and uses thereof.

3.

发明申请
COMPOSITION FOR DIAGNOSIS AND TREATMENT OF ALCOHOLIC LIVER DISEASE, USING CHANGE IN SHORT-CHAIN FATTY ACID PRODUCING GUT BACTERIAL COMMUNITY 有权

公开(公告)号：US20210052674A1

公开(公告)日：2021-02-25

申请号：US16648358

申请日：2018-09-28

申请人： KoBioLabs, Inc.

发明人： Gwangpyo KO , Boram SEO , Woon Ki KIM , Kyungchan JEON

IPC分类号： A61K35/741 , A23L33/135 , C12N1/20 , C12Q1/06

摘要： The present invention relates to a microorganism which can act as a biomarker of alcoholic fatty liver disease, and relates to a pharmaceutical composition for preventing or treating alcoholic fatty liver disease, a food composition for preventing or improving alcoholic fatty liver disease, or a probiotics composition for preventing or improving alcoholic fatty liver disease, comprising the strain as an active ingredient.